JILLIAN PERAGALLO: Open Payments
NPI 1376944231 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 87 payments from 13 companies in 2025. Trend: 2023 $747 · 2024 $1,280 · 2025 $1,361
Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $360 |
| Medtronic, Inc. | 14 | $258 |
| Collegium Pharmaceutical, Inc. | 25 | $206 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $200 |
| Azurity Pharmaceuticals, Inc. | 4 | $68 |
| Lundbeck LLC | 3 | $53 |
| Forte Bio-Pharma LLC | 2 | $53 |
| Valinor Pharma, LLC | 3 | $50 |
| Avanos Medical | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
Products named: INCEPTIV, RELISTOR, QULIPTA, Belbuca, BOTOX, HORIZANT, VYEPTI, PROLATE.
Industry payments across NY — which companies pay providers there.
